国常会：要推动我国生物医学技术创新发展，加快技术研发和成果转化应用

Core Viewpoint - The State Council, led by Premier Li Qiang, has approved the draft regulations for the management of clinical research and clinical translation applications of biomedical new technologies, aiming to enhance innovation and development in China's biomedical technology sector [1] Group 1: Policy and Regulation - The meeting emphasizes the need to promote innovation and development in biomedical technology, accelerating research and the application of results [1] - It highlights the importance of ensuring safety and regulation in clinical research to safeguard the quality of clinical applications [1] Group 2: Industry Development - The focus is on upgrading the biopharmaceutical industry to create new competitive advantages [1] - The initiative aims to better enhance public health and well-being through effective innovation outcomes [1]